Senior Management

Jan Keltjens [Bio]

President, Chief Executive Officer

Ginette Gagne

Chief Financial Officer

Jean-Pierre Desmarais

Chief Scientific Officer

Marwan Abboud

Vice President, Technology & Intellectual Property

Allan Zingeler

Vice-President, Global Marketing and Business Development

Olivier Bataille

Vice-President, Product Development and Operations

Beatrice E. Despotopoulos

Vice-President, Human Resources and Talent Development

Frank Vandeputte

Vice President, Europe

Cryofact

Approximately half of arrhythmia procedures performed around the world fall into the peri-nodal category where precision and safety are critical. In approximately 1% of these procedures, when traditional heat-based RF ablation is used, the patient's AV node is damaged. As a result, the patient may require a pacemaker for the remainder of his or her life. CryoCath's Freezor® offers physicians a safer alternative.

Keep up to date on CryoCath